Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer: biomarker evaluation of the IMpassion130 study - Emens, Leisha Ann; Molinero, Luciana; Loi, Sherene; Rugo, Hope S; Schneeweiss, Andreas; Diéras, Véronique; Iwata, Hiroji; Barrios, Carlos H; Nechaeva, Marina; Nguyen-Duc, Anh; Chui, Stephen Y; Husain, Amreen; et al. (Journal of the National Cancer Institute, 2021)
Gesehen am 09.12.2021